Literature DB >> 10809956

Individual and combined effect of granulocyte-macrophage colony-stimulating factor and prolactin on maturation of dendritic cells from blood monocytes under serum-free conditions.

L Matera1, A Galetto, M Geuna, K Vekemans, E Ricotti, M Contarini, F Moro, G Basso.   

Abstract

Prolactin (PRL) shares structural and functional features with haemopoietic factors and cytokine peptides. Dendritic cells (DC) are involved in both initiating the primary and boosting the secondary host immune response and can be differentiated in vitro from precursors under the effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) plus other factors. Because PRL has been shown to functionally interact with GM-CSF, we have addressed its role on GM-CSF-driven differentiation of DC. Monocytic DC precursors from peripheral blood mononuclear cells (PBMC) were enriched either by adhesion to a plastic surface or CD14-positive selection and cultured for 7 days in serum-free medium containing GM-CSF, interleukin (IL)-4 and PRL, alone or in combination. Cells with large, veiled cytoplasm, expressing major histocompatibility complex (MHC) class II and the costimulatory molecules CD80, CD86 and CD40 and lacking the monocyte marker CD14, were considered as having the phenotype of cytokine-generated DC. Functional maturation was assessed by proliferation and interferon-gamma (IFN-gamma) release of allogeneic T lymphocytes. Physiological (10-20 ng/ml) concentrations of PRL interacted synergistically with GM-CSF and the effect was similar to that induced by IL-4 on GM-CSF-driven DC maturation. When used alone, the physiological concentrations of PRL were inhibitory, whereas higher concentrations (80 ng/ml) were stimulatory. The synergistic effect of PRL may in part be caused by its ability to counteract the down-modulation of the GM-CSF receptor observed in serum-free conditions. These data provide further evidence of the significance of PRL in the process of T lymphocyte activation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10809956      PMCID: PMC2326992          DOI: 10.1046/j.1365-2567.2000.00996.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  32 in total

Review 1.  The dendritic cell system and its role in immunogenicity.

Authors:  R M Steinman
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

2.  Up-modulation of interferon-gamma mediates the enhancement of spontanous cytotoxicity in prolactin-activated natural killer cells.

Authors:  L Matera; M Contarini; G Bellone; B Forno; A Biglino
Journal:  Immunology       Date:  1999-11       Impact factor: 7.397

3.  Prolactin receptors on human T and B lymphocytes: antagonism of prolactin binding by cyclosporine.

Authors:  D H Russell; R Kibler; L Matrisian; D F Larson; B Poulos; B E Magun
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

4.  Regulation of interleukin 2-driven T-lymphocyte proliferation by prolactin.

Authors:  C V Clevenger; D H Russell; P M Appasamy; M B Prystowsky
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

5.  Independent and synergistic effect of interleukin-2 and prolactin on development of T- and NK-derived LAK effectors.

Authors:  A Cesano; E Oberholtzer; M Contarini; M Geuna; G Bellone; L Matera
Journal:  Immunopharmacology       Date:  1994 Jul-Aug

6.  Prolactin-induced mitogenesis of lymphocytes from ovariectomized rats.

Authors:  S M Viselli; E M Stanek; P Mukherjee; W C Hymer; A M Mastro
Journal:  Endocrinology       Date:  1991-08       Impact factor: 4.736

Review 7.  Prolactin and growth hormone in the regulation of the immune system.

Authors:  R R Gala
Journal:  Proc Soc Exp Biol Med       Date:  1991-10

8.  Enhanced yields of gamma interferon in prolactin treated human peripheral blood mononuclear cells.

Authors:  T C Cesario; S Yousefi; G Carandang; N Sadati; J Le; N Vaziri
Journal:  Proc Soc Exp Biol Med       Date:  1994-01

9.  Prolactin receptor signaling: shared components with the T-cell antigen receptor in Nb2 lymphoma cells.

Authors:  J S Krumenacker; D W Montgomery; D J Buckley; P W Gout; A R Buckley
Journal:  Endocrine       Date:  1998-12       Impact factor: 3.925

10.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.

Authors:  F Sallusto; A Lanzavecchia
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

View more
  6 in total

1.  Multiple cAMP-induced signaling cascades regulate prolactin expression in T cells.

Authors:  S Gerlo; P Verdood; E L Hooghe-Peters; R Kooijman
Journal:  Cell Mol Life Sci       Date:  2006-01       Impact factor: 9.261

2.  Effect of prolactin on carcinoembryonic antigen-specific cytotoxic T lymphocyte response induced by dendritic cells.

Authors:  L Matera; E Beltramo; E Martinuzzi; S Buttiglieri
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

3.  Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations.

Authors:  Florian Then Bergh; Tania Kümpfel; Erina Schumann; Ulrike Held; Michaela Schwan; Mirjana Blazevic; Axel Wismüller; Florian Holsboer; Alexander Yassouridis; Manfred Uhr; Frank Weber; Martin Daumer; Claudia Trenkwalder; Dorothee P Auer
Journal:  BMC Neurol       Date:  2006-05-23       Impact factor: 2.474

Review 4.  Prolactin: Friend or Foe in Central Nervous System Autoimmune Inflammation?

Authors:  Massimo Costanza; Rosetta Pedotti
Journal:  Int J Mol Sci       Date:  2016-12-02       Impact factor: 5.923

5.  Lipopolysaccharide induces the expression of an autocrine prolactin loop enhancing inflammatory response in monocytes.

Authors:  Gonzalo López-Rincón; Ana L Pereira-Suárez; Susana Del Toro-Arreola; Pedro E Sánchez-Hernández; Alejandra Ochoa-Zarzosa; José Francisco Muñoz-Valle; Ciro Estrada-Chávez
Journal:  J Inflamm (Lond)       Date:  2013-06-03       Impact factor: 4.981

Review 6.  Prolactin and Autoimmunity.

Authors:  Vânia Vieira Borba; Gisele Zandman-Goddard; Yehuda Shoenfeld
Journal:  Front Immunol       Date:  2018-02-12       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.